Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition
NCT07468604
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Autonomic Dysfunction
Interventions
DRUG:
5 mL of 0.25% bupivacaine with epinephrine (1:200,000)
OTHER:
Sham Group
Sponsor
University Health Network, Toronto